Ardent Health (NYSE:ARDT) Stock Price Expected to Rise, Stephens Analyst Says

Ardent Health (NYSE:ARDT) had its price objective lifted by investment analysts at Stephens from $13.00 to $21.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Stephens‘s target price suggests a potential upside of 21.92% from the stock’s current price.

Several other analysts have also issued reports on ARDT. Weiss Ratings upgraded Ardent Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, October 6th. Guggenheim lifted their price objective on Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Leerink Partners restated an “outperform” rating and issued a $14.00 price objective on shares of Ardent Health in a research note on Friday, September 18th. Wall Street Zen downgraded shares of Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Finally, Royal Bank Of Canada increased their target price on shares of Ardent Health from $13.00 to $18.00 and gave the stock an “outperform” rating in a research report on Friday. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $13.54.

Ardent Health Stock Performance

Shares of NYSE:ARDT traded up $1.32 during midday trading on Friday, reaching $17.23. The company had a trading volume of 2,747,768 shares, compared to its average volume of 474,621. The company’s 50 day moving average price is $11.32 and its 200 day moving average price is $10.05. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61. The stock has a market cap of $2.43 billion, a P/E ratio of 16.65, a P/E/G ratio of 3.68 and a beta of 0.58. Ardent Health has a 52-week low of $7.71 and a 52-week high of $17.67.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.23 by $0.08. Ardent Health had a net margin of 2.27% and a return on equity of 8.49%. The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.60 billion. As a group, sell-side analysts anticipate that Ardent Health will post 0.96 EPS for the current fiscal year.

Institutional Investors Weigh In On Ardent Health

Several large investors have recently added to or reduced their stakes in ARDT. Allworth Financial LP bought a new stake in Ardent Health in the 2nd quarter worth approximately $28,000. Integrated Wealth Concepts LLC bought a new position in shares of Ardent Health during the 2nd quarter valued at $57,000. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Ardent Health during the 3rd quarter valued at $61,000. Abel Hall LLC purchased a new position in Ardent Health in the 1st quarter worth $87,000. Finally, Brighton Jones LLC purchased a new position in Ardent Health in the 3rd quarter worth $110,000.

Ardent Health Company Profile

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.